The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer
 
Stock and Other Ownership Interests - Orion; Sartar Therapeutics
Consulting or Advisory Role - Orion
Research Funding - Defense Therapeutics (Inst); Mersana (Inst)
Patents, Royalties, Other Intellectual Property - Sartar Therapeutics

Darolutamide plus androgen-deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP).
 
Alicia Morgans
Stock and Other Ownership Interests - Vertex (I)
Honoraria - Advanced Accelerator Applications; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Curium Pharma; Exelixis; Janssen; Janssen Oncology; Macrogenics; Merck; Myovant Sciences; Pfizer; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Exelixis; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Myovant Sciences; Myriad Genetics; Novartis; Sanofi
Research Funding - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Dendreon; Genentech; Myovant Sciences; Pfizer; Sanofi; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Sanofi; Telix Pharmaceuticals
 
Tamim Niazi
Stock and Other Ownership Interests - Knight Pharmaceuticals
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Merck; Sanofi; Tersera; Tolmar
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Juergen Gschwend
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
 
Ashley Ross
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Decipher Biosciences; Janssen Biotech; Lantheus Medical Imaging; Myovant Sciences; tempus
Consulting or Advisory Role - Astellas Pharma; BillionToOne
Speakers' Bureau - Tempus
 
Thomas Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich; Lantheus Medical Imaging
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Novartis (Inst); Philips Healthcare (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Alex Chehrazi-Raffle
Honoraria - ASCO; EPG Health; Medical Oncology Association of Southern California; OncLive/MJH Life Sciences
Consulting or Advisory Role - Aveo Inc; Eisai; Exelixis; Seagen
Speakers' Bureau - Exelixis
Research Funding - Exelixis
Travel, Accommodations, Expenses - Bayer
 
Stephane Supiot
Honoraria - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; MSD; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; MSD; Novartis
Research Funding - Astellas Pharma; AstraZeneca; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; MSD; Novartis
 
Philippe Barthelemy
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Andreas Røder
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ferring; Johnson & Johnson; MSD; Orion; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ferring; Johnson & Johnson; MSD; Orion; Pfizer
Research Funding - Bayer; MSD; Pfizer
Travel, Accommodations, Expenses - Intuituve; Medtronic
 
Andrea Gomes
Honoraria - Adium Pharma; Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology
Consulting or Advisory Role - Bayer; Janssen Oncology
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology
Research Funding - AstraZeneca; Bayer; Janssen Oncology; MSD Oncology; Roche
Travel, Accommodations, Expenses - Janssen Oncology
 
Bernardo Herrera Imbroda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson; MSD
Speakers' Bureau - Astellas Pharma; Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson
Travel, Accommodations, Expenses - Bayer; Ipsen; Johnson & Johnson; Recordati
 
Matthieu Gratton
Consulting or Advisory Role - Bayer; Knight Therapeutics; Tolmar
Research Funding - Bayer
 
Carmen Belen Congregado Ruiz
No Relationships to Disclose
 
Heikki Joensuu
No Relationships to Disclose
 
Miryana Dimova-Dobreva
No Relationships to Disclose
 
Marie-Aude Le Berre
Employment - Bayer
 
Iris Kuss
Employment - Bayer Germany
Stock and Other Ownership Interests - Bayer; Bayer
 
Karim Fizazi
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Novartis (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Janssen Oncology (Inst); MSD (Inst); Novartis (Inst); Orion; Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; MSD; Pfizer